Brief: Intelgenx Announces Settlement Of Suboxone Patent Litigation
14/05/2018 13:13
May 14 (Reuters) - Intelgenx Technologies Corp IGX.V :
* INTELGENX ANNOUNCES SETTLEMENT OF SUBOXONE® PATENT
LITIGATION
* INTELGENX TECHNOLOGIES - SETTLEMENT DEAL PERMITS PAR TO
BEGIN
SELLING GENERIC VERSION OF SUBOXONE FILM ON JAN 1, 2023, OR
EARLIER UNDER CIRCUMSTANCES
Source text for Eikon: ID:nGNX6DlwG8
Further company coverage: IGX.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Intelgenx Technologies
See all newsBrief: Intelgenx Obtains Court-Approval Of Sale & Investment Solicitation Process
Brief: Intelgenx Initiates Restructuring Proceedings Under CCAA To Implement Review Of Its Strategic Alternatives
Brief: Intelgenx Initiates Restructuring Proceedings Under The CCAA
Brief: IntelGenx Says First Parkinson’s Disease Patients Dosed With Montelukast VersaFilm in Mid-Stage Clinical Trial
Brief: IntelGenx Updates Status Of Buprenorphine Buccal Film ANDA